News

FDA won’t approve COVID shot for healthy, non-elderly population
The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials ...
FDA panel debates COVID vaccine recipe as questions swirl about fall shots
Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter ...
Trump’s FDA just changed COVID vaccine rules for 2025 — will you still qualify for boosters under the new guidelines?
FDA COVID vaccine update is stirring major public attention as a new policy limits fall COVID-19 booster shots to seniors and ...
COVID Shots for Kids Are Over
The FDA’s new approach to boosters could mean that kids will no longer be able to get vaccinated against the disease to begin with.
Changes are happening around COVID-19 vaccines: Here's what to know
The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...
Wellbeing Whisper on MSN13h
Navigating the New COVID-19 Vaccine Rules Who Can Get the Updated Shots This Fall
The truth is that for most of that, for many Americans, we simply do not know the answer to whether or not they should be ...
Wellbeing Whisper on MSN14h
FDA's New Covid-19 Vaccine Strategy Could Leave Millions of Healthy Adults Without Access to Boosters
We have to admit to ourselves that America is deeply divided on the policy issue of repeat COVID-19 vaccine doses or boosters ...
Scripps News on MSN7h
FDA committee meets to discuss COVID vaccine target for fall amid access restrictions
The FDA's new vaccine guidelines focus on older adults, citing insufficient evidence for the need for additional COVID shots ...
Covid Vaccine Boosters Won't Be Available for Healthy Adults Under 65. How Will That Work?
"With the COVID pandemic behind us, it is time to adopt a common-sense approach to COVID policy," a spokesperson for the FDA ...
Health and Me on MSN6h
10 Things About The New COVID-19 Vaccine Plan By Trump Administration
The Trump administration's new COVID-19 vaccine plan limits access to high-risk groups, requiring further trials for low-risk individuals, marking a major policy shift amid scientific uncertainty and ...
Everyday Health on MSN23h
FDA to Limit COVID-19 Vaccines to Older and High-Risk Americans
The FDA is moving to restrict COVID vaccination to adults 65 and older and other particularly vulnerable people. Learn what’s ...
pharmaphorum19h
Jazz buys KRAS inhibitors from Redx in $880m deal
Jazz Pharmaceuticals has agreed another pipeline-building deal, this time paying $10 million upfront for rights to a KRAS inhibitor programme from UK biotech Redx Pharma, continuing a move into ...